ELOVL2 and neoplasm: RNA-seq data from 12 paired normal tissues and LUAD tissues collected from Tongren Hospital showed that SLCO1B3 (logFC = 4.23, p = 0.01), CD79A (logFC = 2.80, p = 0.00), LDHA (logFC = 1.41, p = 0.00), NPAS2 (logFC = 1.39, p = 0.01), PLEKHA6 (logFC = 1.23, p = 0.00), ANGPTL4 (logFC = 0.85, p = 0.04), and CIDEC (logFC = 1.82, p = 0.00) increased, while HACD1 (logFC = −1.67, p = 0.00), CYP17A1 (logFC = −1.91, p = 1.00), MTMR10 (logFC = −1.03, p = 0.08), and ELOVL2 (logFC = −0.16, p = 0.89) decreased in tumor (Figure 9C).